Pierre Fabre is a French pharmaceutical and dermo-cosmetical company operating in more than 45 countries. 35-year experience in innovation, development, manufacturing and commercialization has brought Pierre Fabre international recognition in oncology. The company has recently reaffirmed oncology as one of its top R&D and commercial priorities, focusing on targeted therapies, biotherapies and immuno-oncology. Its therapeutic areas cover high unmet medical needs, including colorectal, breast, lung cancers, melanoma and pre-cancerous conditions like actinic keratosis. Pierre Fabre‘s expertise in dermatology, combined with the one in oncology, puts the company in a unique position to fight against skin cancers from multiple angles. Pierre Fabre is mostly owned by the FOUNDATION Pierre Fabre, a government-recognized public-interest foundation.
For reporting of any suspected adverse reaction which might be related to any Pierre Fabre product, please use the following address:
For any medical information you might need related to any Pierre Fabre product, please use the following address: